Cannabis Report
Home > Boards > US OTC > Medical - Equipment >

Lifeline Biotechnologies, Inc. (LLBO)

Add LLBO Price Alert      Hide Sticky   Hide Intro
Moderator: rmilman
Search This Board: 
Last Post: 6/17/2018 7:10:45 PM - Followers: 269 - Board type: Free - Posts Today: 0

Lifeline Biotechnologies Provides Information To The Public And Its Shareholders

Cyrcadia, Inc. – 2017 Year End and 2018 Look Forward Newsletter

by admin | Feb 21, 2018 | NewsFebruary 27, 2018 Cyrcadia, Inc. (“CI”) extends its thanks and appreciation in your interest and support of our endeavors. We are taking this opportunity to provide an update, as well as apprise you of upcoming expectations. License and Cooperation Agreement with Cyrcadia Asia (“CA”) – Status Earlier in 2017 CI entered into an Agreement with CA, whereby CA assumed the responsibility and funding of the design, development and delivery of a scalable, commercializable iTBra™ system including upgraded hardware and the full suite of application software as well as automation of our proprietary Artificial Intelligence Analytics. The estimated cost of development with Jabil and Mobile Now is approximately $1.2 to $1.5 million US. As such, the agreement calls for CA to provide timely reporting and status of product development including timelines, milestones and dates of completion and delivery of product (market readiness, product volume availability and delivery terms and schedules). Many strides have been made in the evolution of the relationship as CA has established its operations, initial staffing and funding. Both CI and CA are in a mode of cooperation, as called for by the Agreement and, presently, both entities are to hold routine meetings where comprehensive updating and reporting will be delivered to CI, enabling implementation of our business, operations and marketing plans. We will be reporting the outcomes of that meeting to move forward on our ability to commercialize the iTBra™ system this year. Given the above, we would like to update on the internal operations that will allow for CI to “hit the ground running” upon product delivery. Status of Product Development and Manufacturing Under CA’s...

Welcome to Lifeline Biotechnologies Inc. (LLBO) Board!!!

Clinical Trial

In Progress - To Be Completed

** Funding for Clinical Trial

** Vendor delivery of testing materials

Completed for Clinical Trial

** Protocol for testing accepted

** Internal Review Board (IRB) approved

** Contract with hospital executed

Prospective Partner

** Stanford University's Canary Research

Research in blood genomics


The Mastascope is an ultraslim, hand held endoscope designed to enter the breast nipple via one of its milk ducts, thus permitting the physician to visualize the interior aspects of the breast. Because many cancers actually begin within an individual milk duct, these intraductal tumors are visualized easily and can be biopsied. This product has been used in leading breast centers in the United Kingdom and other countries with great success. Lifeline has obtained a CE mark for marketing and distribution in Europe. 


Lifeline has developed and tested an ultraslim endoscope to directly visualize the ovarian surface in the search for cancer. This is of great advantage to physicians, because neither MRI, X-Ray nor Ultrasonography can provide accurate assessments of subtle surface changes. Initial reports of clinical usage have been encouraging.

About $LLBO - Lifeline Biotechnologies, Inc.

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded. 

Safe Harbor:

This publication includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company's product or market acceptance of the product and regulatory and shareholder approval for anticipated actions. became Cyrcadia Health

$LLBO is Cyrcadia's largest shareholder at approximately 40%

Transfer Agent

OTC Corporate Transfer Service Co.
52 Maple Run Drive
Jericho, NY 11753

Share Structure
Shares Outstanding 3,026,680,967 a/o Sep 30, 2014
Float 650,000,000 a/o Jun 30, 2009
Authorized Shares 4,950,000,000 a/o Sep 30, 2014
Par Value 0.001

Company Information

About Lifeline Biotechnologies:

Lifeline Biotechnologies, Inc. (OTC Market: LLBO) founded in 1994 is based in Reno, NV.  LLBO has invested over $10M in a device and process for early detection of breast tissue abnormalities some of which are cancerous or pre-cancer.  Three “Proof of Concept” clinical trials of over 500 women have been completed and three patents (one hardware, two software) have been awarded.

About Cyrcadia Health

Cyrcadia Health founded in 2008, is based in Reno, Nev. The Cyrcadia Health product line is a device and software service that detects breast tissue abnormalities leading to health risk assessment and management including early breast cancer identification. Three clinical trials with over 650 participants have achieved proof of concept and superior outcomes when compared to other diagnostic protocols. Cyrcadia Health technology is exclusively licensed for development, manufacturing and marketing worldwide from Lifeline Biotechnologies, Inc (OTC Market: LLBO). Cyrcadia Health is planning a final, limited clinical trial and a 510k device classification to validate the fourth generation of the FWS product. Cyrcadia Health is preparing to apply for a Euro CE Mark to market in the European Union and Asia Pacific markets. See Cyrcadia Health video, “Breast Cancer Tumor Progression” at

iTBra in the News

ABC 7 News - February 5, 2015


ABC 7 News - February 5, 2015

ABC 7 News - January 30, 2015

Good Monring America apperance coming....
Quote from the March 12, 2015 PR

They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.

Could a Bra Actually Detect Breast Cancer?
By Smithsonian Magzine



Documentary Movie: Detected coming....
Funded by Cisco
Detected Trailer...

Detected trailer on Cisco's facebook page
Detected: Behind the Scenes with Ironbound Films
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea

How the Internet of Everything is Changing Healthcare

Can the IoE Save Lives? Connected Bra Could Predict Cancer
By: Cisco's Senior Vice President and Chief Marketing Officer

Detected Website
Detected Facebook
Detected Twitter

Partnered with Flextronics

Cyrcadia Health Partners

In Israel at Flextronics


iTBra Already Saved Nedra Lindsay's Life - See Her Story

Final Clinical Trials, FDA plans and other info from - March 12, 2015 Press Release

...Cyrcadia prepares to enter the final clinical trials that will be conducted at El Camino Hospital (ECH) in Mountain View, CA and the Ohio State University (OSU) Oncology Hospital in Columbus, OH. The trials have been approved through Investigational Review Boards (IRB's) of ECH and are currently undergoing the review process at OSU. The ECH trial is slated for start before the end of April 2015. The trials are expected to be completed in four to 6 months. On completion Cyrcadia will obtain CE Marking allowing for sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016.


It is interesting to note that Dr. Farrar at OSU will be the primary investigator for the trials conducted at OSU. Dr. Farrar headed the original "proof of concept" study that was conducted at OSU.


Stanford University Canary Center for Early Cancer Detection has pledged $187,000 to help fund the equipment for the trials at El Camino Hospital.


They also interviewed Rob Royea (Cyrcadia's President) for a feature story on Good Morning America expected to air in the next coming months.


Detected Movie Youtube channel
Video News Clipping ABC7 Los Angeles Health News - Breast Cancer Detecting Bra
Detected: Behind the Scenes with Ironbound Films
Wearable & Social Breast Cancer Screening
Meet Chief Evangelist Behind Cancer-Detecting iTBra, Rob Royea
How the Internet of Everything is Changing Healthcare
GameChanger of the Year: Cyrcadia

$LLBO infograph, DD in a nutshell

Cannabis Report
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
#25416  Sticky Note Cisco very happy with 82% effective diognoses rate confirm 04/17/18 11:26:23 AM
#25703   If you do not care what anyone does, MEAD II 06/17/18 07:10:45 PM
#25702   $LLBO$. YOU KNOW WHY I STILL HOLD LLBO? Chaka 06/17/18 04:05:07 PM
#25701   do not care what anyone here does.the lies PharrmaBro 06/17/18 01:46:01 PM
#25700   Well someone is in panic mode intexp 06/17/18 11:03:31 AM
#25699   PB, this article was written 6 yrs. ago! Arnie1 06/17/18 09:26:16 AM
#25698   First Warning Systems plans on filing for FDA PharrmaBro 06/17/18 12:19:08 AM
#25697   "LIES PharrmaBro 06/16/18 11:55:59 PM
#25696 PharrmaBro 06/16/18 11:44:54 PM
#25695   I have been here for to many moons PharrmaBro 06/16/18 11:41:07 PM
#25694   #speculation works both ways. For the negative and rmilman 06/16/18 08:08:21 PM
#25693   And try to be positive for one time, leprisonnier 06/16/18 03:40:11 AM
#25692   It's the weekend's. Chaka 06/16/18 02:53:46 AM
#25689   A Systematic Review of Wearable Systems for Cancer PharrmaBro 06/16/18 01:49:01 AM
#25687   #speculation that's all it is. PharrmaBro 06/15/18 03:29:25 PM
#25686   Yes, nice find sven! rmilman 06/14/18 09:30:57 PM
#25685   LOL!!! This product is not going to fail, rmilman 06/14/18 09:30:12 PM
#25684   So Cisco, is talking about Cyrcadia. Article came Wrestler 06/14/18 07:29:00 PM
#25683 sven 06/14/18 11:49:48 AM
#25682   Yep and it's been there a while .. intexp 06/14/18 11:30:37 AM
#25681   Does anyone know why on the Cyrcadia website PCM111 06/14/18 11:23:05 AM
#25677 Multi Cancer detection co. Is valued at 60 PharrmaBro 06/13/18 03:45:05 PM
#25676   Cyrcadia Health LLBO: 07-.12PPS confirm 06/13/18 03:09:55 PM
#25675   Everyday same people say same thing. Soon we PharrmaBro 06/13/18 02:49:55 PM
#25674   The man behind the curtain sound so convincing PharrmaBro 06/13/18 01:55:13 PM
#25673   How many year we say soon we will PharrmaBro 06/13/18 01:49:27 PM
#25672   What I learn is people are easily fooled PharrmaBro 06/13/18 01:45:09 PM
#25670   unfortunately there is nothing to do ..... is Penblanc 06/13/18 11:25:42 AM
#25668   Exactly!!!! Luckyyu 06/13/18 12:33:36 AM
#25667   Yup!!! $$$LLBO$$$ Luckyyu 06/13/18 12:18:57 AM
#25664   Trial resumption after years of holder thinking that PharrmaBro 06/12/18 06:58:08 PM
#25663   Our product team and strategic partners are adjusting PharrmaBro 06/12/18 06:48:34 PM
#25662   Raising money at .50 still my dears is PharrmaBro 06/12/18 06:43:42 PM
#25661   Cyrcadia Health April 30, 2018, Reno, NV. Clinical Trial Luckyyu 06/12/18 08:35:12 AM
#25660   Cyrcadia Health May 14, 2018, Reno, NV. Artificial Intelligence Luckyyu 06/12/18 08:28:09 AM
#25659   Cyrcadia Health Reno, NV May 29, 2018, Cyrcadia Health Luckyyu 06/12/18 07:51:44 AM
#25658   ..summertime,...and no news... mark5050 06/11/18 11:32:30 PM
#25657   Nothing but sells PharrmaBro 06/11/18 08:45:27 PM
#25655   Watching the Tape Move for Lifeline Biotech (LLBO) Wrestler 06/10/18 06:36:29 AM
#25654   Their name is still out there and mentioned Wrestler 06/09/18 04:20:51 PM
#25653 Wrestler 06/09/18 04:08:21 PM
#25652  Restored Guys shhh please don't tell anyone about this PharrmaBro 06/09/18 03:08:41 PM
#25651   Less than .01 in money traded.llbo has less PharrmaBro 06/09/18 03:03:01 PM
#25650   Everyone should be doing their own DD as MEAD II 06/09/18 02:38:29 PM
#25649   Very good indications of today's volume that the Arnie1 06/08/18 11:19:52 PM
#25648   Those who are here have weathered the storm MEAD II 06/08/18 06:43:21 PM
#25647   Voo.. It's obvious why. Chaka 06/08/18 05:03:18 PM
#25646   Thank you for clearing that up. So PB MEAD II 06/08/18 07:14:52 AM
#25645   But why did he change his alias?? It voo 06/08/18 04:27:17 AM
#25644   Everything you speak off has been repeatedly.this info voo 06/08/18 04:26:25 AM
#25643   Investors need to do their own DD. Chaka 06/07/18 11:50:56 PM